Search - tctmd.com

Displaying 221 - 240 of 1120

Sort: Relevancy | Date

Presentation TCT 2016

Neovasc Tiara: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Anson Cheung

October 31, 2016

Presentation TCT 2016

A Practical Algorithm for Managing Para-Valvular Regurgitation After TAVR

Presenter: Neil E. Moat, John G. Webb, Scott Lim

October 31, 2016

Presentation TCT 2016

PARTNER 2 and SAPIEN 3 Critique: Pros and Cons

Presenter: William A. Gray, Stephan Windecker

October 31, 2016

Presentation TCT 2016

Tendyne: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, David W.M. Muller

October 31, 2016

Presentation TCT 2016

Complications 1. Para-Valvular Regurgitation: Should Mild Para-Valvular Regurgitation After TAVR Be Treated?

Presenter: Neil E. Moat, John G. Webb, Jeffrey J. Popma

October 31, 2016

Presentation TCT 2016

TCT 1492: Double Valve Case TAVR and TMVR in Native Annulus at the Same Time

Presenter: David R. Holmes Jr., Clifford J. Kavinsky, M. Rizwan Sardar

October 31, 2016

Presentation TCT 2016

TCT 1497:First Case of Transcatheter Aortic and Mitral Valve Replacements

Presenter: Jean-Claude Laborde, Thomas Walther, Hellmuth Weich

October 31, 2016

Presentation TCT 2016

Complications of Structural Heart Disease Intervention

Presenter: George S. Hanzel, Mauricio G. Cohen

October 31, 2016

Presentation TCT 2016

Case #2: A TAVR Complication to Learn From

Presenter: Antonio Colombo, Jeffrey W. Moses, Augusto D. Pichard

October 31, 2016

Presentation TCT 2016

CardiAQ: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Gian Paolo Ussia

October 31, 2016

Presentation TCT 2016

Trial #6 - The Essentials ofPARTNER 2 and SAPIEN 3 - TAVR In Intermediate Risk Patients, and Improved TAVR Devices

Presenter: William A. Gray, Stephan Windecker, Vinod H. Thourani

October 31, 2016

Presentation TCT 2016

Updates on New Adjunctive Pharmacotherapy Clinical Trials for TAVR

Presenter: Raj Makkar, Lars Sondergaard, Davide Capodanno

October 31, 2016

Presentation TCT 2016

Case Resolution: How Did We Treat this Patient?

Presenter: Nick Curzen, Michael Mahmoudi

October 31, 2016

Presentation TCT 2016

Complications That Can Occur After Transcatheter Mitral Valve Replacement

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Neil E. Moat

October 31, 2016

Presentation TCT 2016

Controversy 5. Adjunctive Pharmacotherapy for TAVR: Real World Usage Patterns of Antiplatelet and Antithrombotic Agents

Presenter: Raj Makkar, Lars Sondergaard, Luis Nombela-Franco

October 31, 2016

Presentation TCT 2016

TCT 1631: Percutaneous Treatment of Multiple LAD-RV Fistula in Heart Transplant Recipient

Presenter: David R. Holmes Jr., Clifford J. Kavinsky, Farzin Beygui

October 31, 2016

Presentation TCT 2016

TCT 1494: Combined Rendezvous Approach With the Direct Flow Medical® Aortic Valve Prosthesis to Treat Concomitant Aortic and Mitral Stenosis

Presenter: Jean-Claude Laborde, Thomas Walther, Ulrich Schafer

October 31, 2016

Presentation TCT 2016

Design Challenges in TMVR: Impossible or Just Near Impossible?

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Juan F. Granada

October 31, 2016

Presentation TCT 2016

TAVR Restenosis: Review of the Literature

Presenter: Nick Curzen

October 31, 2016

Presentation TCT 2016

Case #1: A TAVR Complication to Learn From

Presenter: Antonio Colombo, Jeffrey W. Moses, Samir R. Kapadia

October 31, 2016

Advertisement

Neovasc Tiara: Design and Clinical Trial Updates

A Practical Algorithm for Managing Para-Valvular Regurgitation After TAVR

PARTNER 2 and SAPIEN 3 Critique: Pros and Cons

Tendyne: Design and Clinical Trial Updates

Complications 1. Para-Valvular Regurgitation: Should Mild Para-Valvular Regurgitation After TAVR Be Treated?

TCT 1492: Double Valve Case TAVR and TMVR in Native Annulus at the Same Time

TCT 1497:First Case of Transcatheter Aortic and Mitral Valve Replacements

Complications of Structural Heart Disease Intervention

Case #2: A TAVR Complication to Learn From

CardiAQ: Design and Clinical Trial Updates

Trial #6 - The Essentials ofPARTNER 2 and SAPIEN 3 - TAVR In Intermediate Risk Patients, and Improved TAVR Devices

Updates on New Adjunctive Pharmacotherapy Clinical Trials for TAVR

Case Resolution: How Did We Treat this Patient?

Complications That Can Occur After Transcatheter Mitral Valve Replacement

Controversy 5. Adjunctive Pharmacotherapy for TAVR: Real World Usage Patterns of Antiplatelet and Antithrombotic Agents

TCT 1631: Percutaneous Treatment of Multiple LAD-RV Fistula in Heart Transplant Recipient

TCT 1494: Combined Rendezvous Approach With the Direct Flow Medical® Aortic Valve Prosthesis to Treat Concomitant Aortic and Mitral Stenosis

Design Challenges in TMVR: Impossible or Just Near Impossible?

TAVR Restenosis: Review of the Literature

Case #1: A TAVR Complication to Learn From

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content